Novozymes A-S (B) Aktie
52,72
EUR
-1,80
EUR
-3,30
%
53,14
EUR
-1,64
EUR
-2,99
%
Werbung
Novozymes A-S (B) Aktie Analyse
| 17.10.12 | Novozymes A-S (B) hold | Deutsche Bank AG | |
| 03.09.12 | Novozymes A-S (B) buy | ING | |
| 28.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 09.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 19.06.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 17.11.11 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 15.10.10 | Novozymes A-S (B) hold | Vontobel Research | |
| 13.08.10 | Novozymes A-S (B) hold | Vontobel Research | |
|
Werbung
|
|||
| 04.05.05 | Novozymes A-S (B) Sector Underperform | Vontobel | |
Werbung
Werbung